Xuedong Liu
Concepts (350)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ubiquitin-Protein Ligases | 10 | 2024 | 154 | 3.340 |
Why?
| Protein Kinases | 8 | 2024 | 318 | 3.150 |
Why?
| Transforming Growth Factor beta | 10 | 2016 | 455 | 2.340 |
Why?
| Keratinocytes | 5 | 2021 | 242 | 1.730 |
Why?
| Adherens Junctions | 2 | 2021 | 25 | 1.460 |
Why?
| S-Phase Kinase-Associated Proteins | 6 | 2013 | 20 | 1.420 |
Why?
| Cell Cycle Proteins | 8 | 2011 | 584 | 1.400 |
Why?
| Triterpenes | 2 | 2022 | 20 | 1.380 |
Why?
| Mitochondria | 5 | 2024 | 876 | 1.210 |
Why?
| Cell Movement | 6 | 2021 | 944 | 1.080 |
Why?
| Depsipeptides | 3 | 2018 | 13 | 1.050 |
Why?
| Thiazoles | 4 | 2018 | 117 | 1.020 |
Why?
| Cell Line | 18 | 2022 | 2775 | 0.980 |
Why?
| Smad Proteins | 3 | 2010 | 38 | 0.960 |
Why?
| Ubiquitin | 7 | 2012 | 64 | 0.950 |
Why?
| Vesiculovirus | 1 | 2024 | 16 | 0.890 |
Why?
| Signal Transduction | 12 | 2020 | 4919 | 0.890 |
Why?
| Carbanilides | 1 | 2024 | 3 | 0.890 |
Why?
| ADAM17 Protein | 2 | 2020 | 33 | 0.830 |
Why?
| Cannabidiol | 2 | 2022 | 108 | 0.820 |
Why?
| Histone Deacetylase Inhibitors | 3 | 2022 | 209 | 0.820 |
Why?
| Enhancer Elements, Genetic | 2 | 2018 | 176 | 0.800 |
Why?
| Spindle Apparatus | 4 | 2012 | 94 | 0.790 |
Why?
| Ubiquitination | 5 | 2014 | 98 | 0.780 |
Why?
| Ubiquitin-Activating Enzymes | 2 | 2012 | 16 | 0.770 |
Why?
| Oleanolic Acid | 1 | 2022 | 9 | 0.770 |
Why?
| CDC2-CDC28 Kinases | 4 | 2013 | 20 | 0.760 |
Why?
| ADAM Proteins | 2 | 2015 | 59 | 0.760 |
Why?
| alpha Catenin | 2 | 2020 | 12 | 0.750 |
Why?
| Protein Binding | 11 | 2019 | 2120 | 0.710 |
Why?
| Mitosis | 2 | 2012 | 180 | 0.680 |
Why?
| Gene Editing | 1 | 2020 | 67 | 0.670 |
Why?
| Exosomes | 1 | 2020 | 95 | 0.650 |
Why?
| Gene Transfer Techniques | 1 | 2020 | 161 | 0.650 |
Why?
| Epithelial Cells | 6 | 2020 | 1064 | 0.640 |
Why?
| Tripterygium | 1 | 2019 | 1 | 0.640 |
Why?
| Wound Healing | 3 | 2021 | 305 | 0.630 |
Why?
| HEK293 Cells | 5 | 2024 | 695 | 0.620 |
Why?
| Smad4 Protein | 3 | 2010 | 38 | 0.600 |
Why?
| Membrane Transport Proteins | 2 | 2019 | 149 | 0.600 |
Why?
| Transcription, Genetic | 5 | 2008 | 1416 | 0.590 |
Why?
| Cell Nucleus | 5 | 2021 | 584 | 0.590 |
Why?
| Amino Acid Sequence | 11 | 2014 | 2056 | 0.590 |
Why?
| Genome | 3 | 2018 | 276 | 0.580 |
Why?
| Histone Code | 1 | 2018 | 31 | 0.570 |
Why?
| HeLa Cells | 5 | 2020 | 611 | 0.570 |
Why?
| Ligands | 3 | 2016 | 620 | 0.570 |
Why?
| Tumor Suppressor Proteins | 3 | 2005 | 314 | 0.560 |
Why?
| Electron Transport Complex III | 1 | 2017 | 15 | 0.560 |
Why?
| Biosensing Techniques | 2 | 2019 | 118 | 0.560 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 17 | 0.560 |
Why?
| Electron Transport Complex II | 1 | 2017 | 24 | 0.550 |
Why?
| Molecular Sequence Data | 12 | 2013 | 2835 | 0.540 |
Why?
| Software | 3 | 2013 | 606 | 0.540 |
Why?
| Receptors, Cell Surface | 1 | 2019 | 380 | 0.530 |
Why?
| Niacinamide | 1 | 2017 | 75 | 0.530 |
Why?
| Phenylurea Compounds | 1 | 2017 | 88 | 0.530 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 169 | 0.530 |
Why?
| Immunoblotting | 4 | 2012 | 305 | 0.520 |
Why?
| Drug Screening Assays, Antitumor | 3 | 2013 | 191 | 0.500 |
Why?
| Cell Line, Tumor | 10 | 2024 | 3186 | 0.490 |
Why?
| Culture Media, Conditioned | 1 | 2016 | 110 | 0.490 |
Why?
| Animals | 27 | 2024 | 35286 | 0.460 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 6 | 2013 | 74 | 0.460 |
Why?
| Fluorescence Resonance Energy Transfer | 2 | 2019 | 175 | 0.450 |
Why?
| Mitochondrial Dynamics | 1 | 2014 | 37 | 0.450 |
Why?
| Phosphorylation | 7 | 2020 | 1710 | 0.450 |
Why?
| Smad2 Protein | 2 | 2014 | 38 | 0.420 |
Why?
| Kinetochores | 3 | 2012 | 49 | 0.420 |
Why?
| Enzyme Activation | 5 | 2015 | 812 | 0.410 |
Why?
| F-Box Proteins | 1 | 2013 | 26 | 0.410 |
Why?
| G1 Phase | 2 | 2010 | 70 | 0.400 |
Why?
| RNA, Small Interfering | 6 | 2020 | 591 | 0.390 |
Why?
| Mice | 15 | 2024 | 16905 | 0.390 |
Why?
| Humans | 41 | 2024 | 129143 | 0.380 |
Why?
| Viral Envelope Proteins | 2 | 2024 | 81 | 0.380 |
Why?
| Antineoplastic Agents | 2 | 2022 | 2045 | 0.380 |
Why?
| High-Throughput Screening Assays | 1 | 2013 | 138 | 0.370 |
Why?
| Disulfides | 1 | 2012 | 97 | 0.370 |
Why?
| Image Processing, Computer-Assisted | 2 | 2016 | 740 | 0.340 |
Why?
| Membrane Glycoproteins | 2 | 2024 | 476 | 0.330 |
Why?
| Smad3 Protein | 2 | 2014 | 43 | 0.320 |
Why?
| Protein-Tyrosine Kinases | 5 | 2011 | 431 | 0.320 |
Why?
| Ubiquitin-Conjugating Enzymes | 2 | 2006 | 13 | 0.320 |
Why?
| Oncogene Proteins v-erbA | 1 | 2009 | 1 | 0.310 |
Why?
| Myogenic Regulatory Factors | 2 | 2006 | 56 | 0.310 |
Why?
| Peptides | 2 | 2013 | 923 | 0.310 |
Why?
| ErbB Receptors | 3 | 2021 | 602 | 0.310 |
Why?
| Parkinson Disease | 1 | 2014 | 460 | 0.310 |
Why?
| Cyclin E | 2 | 2005 | 23 | 0.310 |
Why?
| SUMO-1 Protein | 2 | 2006 | 20 | 0.300 |
Why?
| Enzyme Inhibitors | 1 | 2012 | 827 | 0.300 |
Why?
| Transforming Growth Factor alpha | 2 | 2020 | 55 | 0.290 |
Why?
| Bone Morphogenetic Proteins | 1 | 2008 | 129 | 0.290 |
Why?
| Ubiquitin-Protein Ligase Complexes | 2 | 2004 | 7 | 0.290 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 2012 | 327 | 0.280 |
Why?
| Regulatory Elements, Transcriptional | 1 | 2007 | 20 | 0.280 |
Why?
| Sequence Alignment | 3 | 2014 | 332 | 0.280 |
Why?
| Protein Inhibitors of Activated STAT | 1 | 2006 | 6 | 0.250 |
Why?
| MADS Domain Proteins | 1 | 2006 | 5 | 0.250 |
Why?
| Mutation | 8 | 2013 | 3705 | 0.250 |
Why?
| Myoblasts | 1 | 2006 | 81 | 0.240 |
Why?
| Mammals | 1 | 2007 | 272 | 0.240 |
Why?
| Green Fluorescent Proteins | 2 | 2020 | 385 | 0.240 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 117 | 0.240 |
Why?
| Microscopy, Fluorescence | 2 | 2019 | 398 | 0.230 |
Why?
| Muscle Fibers, Skeletal | 1 | 2006 | 187 | 0.230 |
Why?
| Computational Biology | 2 | 2007 | 596 | 0.230 |
Why?
| Genome, Human | 1 | 2006 | 392 | 0.220 |
Why?
| Cell Cycle | 2 | 2021 | 588 | 0.220 |
Why?
| Ligases | 1 | 2004 | 30 | 0.220 |
Why?
| Models, Molecular | 5 | 2013 | 1485 | 0.220 |
Why?
| Transcriptional Activation | 1 | 2006 | 367 | 0.220 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 648 | 0.220 |
Why?
| Down-Regulation | 1 | 2006 | 636 | 0.210 |
Why?
| Albumins | 1 | 2024 | 103 | 0.210 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2003 | 69 | 0.210 |
Why?
| Recombinant Proteins | 4 | 2010 | 1304 | 0.200 |
Why?
| Amino Acid Motifs | 4 | 2011 | 214 | 0.200 |
Why?
| Telomeric Repeat Binding Protein 1 | 2 | 2013 | 4 | 0.200 |
Why?
| Epidermal Growth Factor | 2 | 2020 | 169 | 0.200 |
Why?
| RNA, Messenger | 4 | 2022 | 2699 | 0.200 |
Why?
| Binding Sites | 4 | 2016 | 1247 | 0.200 |
Why?
| Glycoproteins | 1 | 2024 | 338 | 0.190 |
Why?
| Extracellular Vesicles | 1 | 2024 | 129 | 0.190 |
Why?
| Substrate Specificity | 3 | 2009 | 368 | 0.190 |
Why?
| Mass Spectrometry | 1 | 2005 | 713 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 3 | 2018 | 2008 | 0.190 |
Why?
| Viral Proteins | 1 | 2024 | 327 | 0.190 |
Why?
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 56 | 0.190 |
Why?
| Acetylation | 2 | 2022 | 244 | 0.180 |
Why?
| Transfection | 3 | 2012 | 914 | 0.180 |
Why?
| Drug Delivery Systems | 1 | 2024 | 332 | 0.180 |
Why?
| Cell Proliferation | 4 | 2020 | 2368 | 0.180 |
Why?
| Argonaute Proteins | 1 | 2020 | 27 | 0.180 |
Why?
| Caspase 9 | 1 | 2020 | 56 | 0.180 |
Why?
| Photochemical Processes | 1 | 2021 | 104 | 0.180 |
Why?
| RAW 264.7 Cells | 1 | 2020 | 49 | 0.180 |
Why?
| Metalloproteases | 1 | 2020 | 44 | 0.170 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 635 | 0.170 |
Why?
| Paracrine Communication | 1 | 2020 | 61 | 0.170 |
Why?
| Protein Structure, Tertiary | 3 | 2010 | 841 | 0.170 |
Why?
| Blotting, Western | 2 | 2016 | 1202 | 0.170 |
Why?
| Histone Deacetylases | 2 | 2022 | 212 | 0.170 |
Why?
| Mink | 3 | 2004 | 12 | 0.170 |
Why?
| Cannabinoids | 1 | 2022 | 153 | 0.170 |
Why?
| Protein Conformation | 3 | 2009 | 860 | 0.170 |
Why?
| Cell Death | 1 | 2021 | 354 | 0.170 |
Why?
| Sequence Homology, Amino Acid | 3 | 2006 | 372 | 0.170 |
Why?
| Integrases | 1 | 2020 | 119 | 0.170 |
Why?
| Neoplasms | 4 | 2022 | 2442 | 0.160 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 383 | 0.160 |
Why?
| Apoptosis | 2 | 2022 | 2491 | 0.160 |
Why?
| Cell Culture Techniques | 2 | 2016 | 336 | 0.160 |
Why?
| Pentacyclic Triterpenes | 1 | 2019 | 15 | 0.160 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2019 | 67 | 0.160 |
Why?
| Hydrazones | 1 | 2019 | 26 | 0.150 |
Why?
| Base Sequence | 3 | 2014 | 2146 | 0.150 |
Why?
| Cells, Cultured | 3 | 2017 | 4075 | 0.150 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2019 | 45 | 0.150 |
Why?
| Enzymes | 1 | 2019 | 65 | 0.150 |
Why?
| Polymerization | 1 | 2019 | 123 | 0.150 |
Why?
| Cytostatic Agents | 1 | 2018 | 6 | 0.150 |
Why?
| Lymphoma, B-Cell | 1 | 2019 | 105 | 0.150 |
Why?
| Models, Biological | 3 | 2016 | 1722 | 0.140 |
Why?
| RNA Interference | 3 | 2016 | 449 | 0.140 |
Why?
| Cell Line, Transformed | 1 | 2018 | 141 | 0.140 |
Why?
| Mice, Inbred BALB C | 1 | 2020 | 1246 | 0.140 |
Why?
| Chromatin Immunoprecipitation | 2 | 2008 | 132 | 0.140 |
Why?
| Oncogenes | 1 | 2018 | 110 | 0.140 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 231 | 0.140 |
Why?
| Catalysis | 2 | 2010 | 307 | 0.140 |
Why?
| Electron Transport | 1 | 2017 | 112 | 0.140 |
Why?
| Antineoplastic Agents, Immunological | 1 | 2019 | 181 | 0.140 |
Why?
| Genes, Reporter | 2 | 2008 | 265 | 0.130 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 1445 | 0.130 |
Why?
| Histones | 2 | 2022 | 588 | 0.130 |
Why?
| Vacuoles | 1 | 2016 | 36 | 0.130 |
Why?
| Microtubules | 1 | 2019 | 263 | 0.130 |
Why?
| Reproducibility of Results | 1 | 2024 | 3077 | 0.130 |
Why?
| RNA-Binding Proteins | 2 | 2016 | 387 | 0.120 |
Why?
| Glycosylphosphatidylinositols | 1 | 2015 | 11 | 0.120 |
Why?
| Haploidy | 1 | 2015 | 24 | 0.120 |
Why?
| Cyclin-Dependent Kinase 2 | 2 | 2005 | 39 | 0.120 |
Why?
| Transcription Factors | 3 | 2008 | 1644 | 0.120 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 441 | 0.120 |
Why?
| RNA Stability | 1 | 2016 | 102 | 0.120 |
Why?
| Valinomycin | 1 | 2014 | 4 | 0.120 |
Why?
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 4 | 0.120 |
Why?
| Virulence Factors | 1 | 2016 | 156 | 0.120 |
Why?
| Salmonella typhimurium | 1 | 2016 | 174 | 0.120 |
Why?
| Algorithms | 2 | 2016 | 1613 | 0.120 |
Why?
| RNA Polymerase II | 1 | 2018 | 317 | 0.120 |
Why?
| Cell Differentiation | 3 | 2007 | 1888 | 0.110 |
Why?
| Cytoprotection | 1 | 2014 | 56 | 0.110 |
Why?
| Glutathione Transferase | 2 | 2005 | 102 | 0.110 |
Why?
| Anaphase-Promoting Complex-Cyclosome | 2 | 2004 | 5 | 0.110 |
Why?
| Drug Resistance, Neoplasm | 1 | 2019 | 751 | 0.110 |
Why?
| Structure-Activity Relationship | 2 | 2013 | 543 | 0.110 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 275 | 0.110 |
Why?
| MAP Kinase Kinase 1 | 1 | 2014 | 75 | 0.110 |
Why?
| Cytoskeleton | 1 | 2015 | 183 | 0.110 |
Why?
| Arginine | 2 | 2005 | 263 | 0.110 |
Why?
| Rabbits | 2 | 2005 | 777 | 0.110 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 96 | 0.110 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1204 | 0.110 |
Why?
| para-Aminobenzoates | 1 | 2013 | 6 | 0.110 |
Why?
| Lysine | 2 | 2006 | 286 | 0.100 |
Why?
| Repressor Proteins | 2 | 2008 | 406 | 0.100 |
Why?
| Time Factors | 4 | 2016 | 6541 | 0.100 |
Why?
| Hydroquinones | 1 | 2013 | 29 | 0.100 |
Why?
| Benzoates | 1 | 2013 | 41 | 0.100 |
Why?
| Active Transport, Cell Nucleus | 2 | 2011 | 113 | 0.100 |
Why?
| Molecular Structure | 2 | 2012 | 478 | 0.100 |
Why?
| Genetic Vectors | 2 | 2005 | 312 | 0.100 |
Why?
| Protein Interaction Maps | 1 | 2013 | 42 | 0.100 |
Why?
| Proteins | 1 | 2019 | 941 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2016 | 2536 | 0.100 |
Why?
| MAP Kinase Signaling System | 1 | 2015 | 312 | 0.100 |
Why?
| Endoplasmic Reticulum | 1 | 2015 | 261 | 0.100 |
Why?
| Liver | 1 | 2020 | 1839 | 0.100 |
Why?
| Adenosine Triphosphate | 1 | 2014 | 478 | 0.100 |
Why?
| Yeasts | 1 | 2012 | 52 | 0.100 |
Why?
| Drug Design | 1 | 2013 | 156 | 0.100 |
Why?
| Carrier Proteins | 2 | 2007 | 742 | 0.090 |
Why?
| Cytokinesis | 1 | 2012 | 48 | 0.090 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2011 | 24 | 0.090 |
Why?
| Proteolysis | 1 | 2012 | 167 | 0.090 |
Why?
| Cell Survival | 2 | 2016 | 1074 | 0.090 |
Why?
| Small Molecule Libraries | 1 | 2012 | 85 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2016 | 157 | 0.090 |
Why?
| Bacterial Proteins | 1 | 2016 | 833 | 0.080 |
Why?
| Cell Extracts | 1 | 2010 | 17 | 0.080 |
Why?
| Rosaniline Dyes | 1 | 2010 | 12 | 0.080 |
Why?
| Cell Fractionation | 1 | 2010 | 56 | 0.080 |
Why?
| Adenine | 1 | 2012 | 256 | 0.080 |
Why?
| Cell Division | 1 | 2011 | 796 | 0.080 |
Why?
| Molecular Imaging | 1 | 2010 | 54 | 0.080 |
Why?
| Nuclear Proteins | 2 | 2015 | 658 | 0.080 |
Why?
| Staining and Labeling | 1 | 2010 | 141 | 0.080 |
Why?
| Glucose | 1 | 2014 | 1000 | 0.080 |
Why?
| Cytoplasm | 1 | 2010 | 265 | 0.080 |
Why?
| Erythroblasts | 1 | 2009 | 15 | 0.080 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 375 | 0.080 |
Why?
| Mad2 Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| Statistics as Topic | 1 | 2010 | 305 | 0.080 |
Why?
| Energy Metabolism | 1 | 2014 | 873 | 0.080 |
Why?
| Macrophages | 1 | 2016 | 1481 | 0.080 |
Why?
| Culture Media | 1 | 2009 | 160 | 0.080 |
Why?
| ADAMTS5 Protein | 1 | 2008 | 4 | 0.080 |
Why?
| Rats | 2 | 2007 | 5479 | 0.070 |
Why?
| Dimerization | 1 | 2008 | 191 | 0.070 |
Why?
| Mice, Knockout | 1 | 2015 | 2871 | 0.070 |
Why?
| RNA-Induced Silencing Complex | 1 | 2007 | 7 | 0.070 |
Why?
| RNA, Helminth | 1 | 2007 | 16 | 0.070 |
Why?
| Body Patterning | 1 | 2008 | 128 | 0.070 |
Why?
| Nocodazole | 1 | 2007 | 16 | 0.070 |
Why?
| Mutagenesis | 1 | 2008 | 181 | 0.070 |
Why?
| Smad1 Protein | 1 | 2007 | 18 | 0.070 |
Why?
| Calcium-Binding Proteins | 1 | 2008 | 211 | 0.070 |
Why?
| Base Pairing | 1 | 2007 | 61 | 0.070 |
Why?
| Drosophila | 1 | 2008 | 140 | 0.070 |
Why?
| Muscles | 1 | 2008 | 320 | 0.070 |
Why?
| Luciferases | 1 | 2007 | 147 | 0.070 |
Why?
| Exons | 1 | 2008 | 341 | 0.070 |
Why?
| Conserved Sequence | 1 | 2007 | 227 | 0.070 |
Why?
| Muscle Development | 1 | 2007 | 103 | 0.070 |
Why?
| Myogenin | 1 | 2006 | 13 | 0.060 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2006 | 87 | 0.060 |
Why?
| MyoD Protein | 1 | 2006 | 32 | 0.060 |
Why?
| Membrane Fusion | 1 | 2006 | 38 | 0.060 |
Why?
| Consensus Sequence | 1 | 2006 | 73 | 0.060 |
Why?
| MEF2 Transcription Factors | 1 | 2006 | 60 | 0.060 |
Why?
| Species Specificity | 1 | 2007 | 574 | 0.060 |
Why?
| Reticulocytes | 1 | 2005 | 18 | 0.060 |
Why?
| Threonine | 1 | 2005 | 44 | 0.060 |
Why?
| Selection, Genetic | 1 | 2007 | 249 | 0.060 |
Why?
| Peptide Mapping | 1 | 2005 | 63 | 0.060 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2007 | 192 | 0.060 |
Why?
| GTPase-Activating Proteins | 1 | 2005 | 81 | 0.060 |
Why?
| Insecta | 1 | 2005 | 63 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 946 | 0.060 |
Why?
| Molecular Weight | 1 | 2005 | 328 | 0.060 |
Why?
| DNA, Complementary | 1 | 2005 | 270 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 1 | 2005 | 361 | 0.060 |
Why?
| Aspartic Acid | 1 | 2004 | 80 | 0.060 |
Why?
| User-Computer Interface | 1 | 2005 | 147 | 0.060 |
Why?
| Xenopus | 1 | 2004 | 85 | 0.060 |
Why?
| Caenorhabditis elegans | 1 | 2007 | 290 | 0.060 |
Why?
| Phosphates | 1 | 2005 | 179 | 0.060 |
Why?
| Staphylococcal Protein A | 1 | 2003 | 11 | 0.050 |
Why?
| S Phase | 1 | 2004 | 75 | 0.050 |
Why?
| Retroviridae | 1 | 2004 | 99 | 0.050 |
Why?
| Genes, Tumor Suppressor | 1 | 2004 | 87 | 0.050 |
Why?
| Endopeptidases | 1 | 2003 | 86 | 0.050 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 136 | 0.050 |
Why?
| Static Electricity | 1 | 2003 | 116 | 0.050 |
Why?
| Gene Deletion | 1 | 2004 | 380 | 0.050 |
Why?
| Cyclin-Dependent Kinases | 1 | 2004 | 129 | 0.050 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 285 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 525 | 0.050 |
Why?
| Histone Deacetylase 1 | 1 | 2022 | 24 | 0.050 |
Why?
| 3' Untranslated Regions | 2 | 2016 | 137 | 0.050 |
Why?
| Oligopeptides | 1 | 2003 | 258 | 0.050 |
Why?
| Epitopes | 1 | 2003 | 470 | 0.050 |
Why?
| Escherichia coli | 1 | 2005 | 766 | 0.050 |
Why?
| MicroRNAs | 1 | 2007 | 676 | 0.040 |
Why?
| Internet | 1 | 2005 | 615 | 0.040 |
Why?
| AMP-Activated Protein Kinases | 1 | 2022 | 190 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2005 | 1833 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 398 | 0.040 |
Why?
| Cholesterol | 1 | 2022 | 412 | 0.040 |
Why?
| DNA | 1 | 2007 | 1396 | 0.040 |
Why?
| Sequence Analysis, RNA | 2 | 2016 | 427 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2019 | 53 | 0.040 |
Why?
| Ions | 1 | 2019 | 66 | 0.040 |
Why?
| Homeostasis | 1 | 2022 | 605 | 0.040 |
Why?
| Drug Synergism | 1 | 2019 | 370 | 0.040 |
Why?
| Computer Simulation | 2 | 2016 | 937 | 0.040 |
Why?
| Histocompatibility Antigens Class I | 1 | 2019 | 200 | 0.040 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 204 | 0.030 |
Why?
| Female | 2 | 2021 | 68493 | 0.030 |
Why?
| Optical Imaging | 1 | 2016 | 56 | 0.030 |
Why?
| Calcium | 1 | 2022 | 1211 | 0.030 |
Why?
| Microbial Viability | 1 | 2016 | 83 | 0.030 |
Why?
| CD59 Antigens | 1 | 2015 | 20 | 0.030 |
Why?
| Phosphotransferases | 1 | 2015 | 24 | 0.030 |
Why?
| Prions | 1 | 2015 | 46 | 0.030 |
Why?
| Cell Adhesion | 1 | 2016 | 452 | 0.030 |
Why?
| Single-Cell Analysis | 1 | 2016 | 274 | 0.030 |
Why?
| Molecular Chaperones | 1 | 2015 | 182 | 0.030 |
Why?
| Protein Transport | 1 | 2015 | 428 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 485 | 0.020 |
Why?
| Kinetics | 1 | 2016 | 1643 | 0.020 |
Why?
| G2 Phase | 1 | 2011 | 36 | 0.020 |
Why?
| Chromosome Segregation | 1 | 2011 | 41 | 0.020 |
Why?
| Lung | 1 | 2004 | 3926 | 0.020 |
Why?
| Quinolines | 1 | 2011 | 156 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 874 | 0.020 |
Why?
| Breast Neoplasms | 1 | 2021 | 2127 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2016 | 1326 | 0.020 |
Why?
| Membrane Proteins | 1 | 2015 | 1116 | 0.020 |
Why?
| Solutions | 1 | 2008 | 150 | 0.020 |
Why?
| Monte Carlo Method | 1 | 2008 | 143 | 0.020 |
Why?
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 27 | 0.020 |
Why?
| RNA Caps | 1 | 2007 | 33 | 0.020 |
Why?
| Endoribonucleases | 1 | 2007 | 72 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2008 | 537 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 2007 | 405 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2007 | 820 | 0.010 |
Why?
|
|
Liu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|